Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114661) titled 'Study on the diagnostic value of attenuation imaging for type 2 diabetes combined with metabolic dysfunction-associated steatotic liver disease' on Dec. 16, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: China-Japan Union Hospital of Jilin University
Condition:
Metabolic dysfunction-associated steatotic liver disease
Intervention:
Gold Standard:Using the magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) as the gold standard:
1. The simple T2DM group (Group S0): MRI-PDFF = 17.1%.
Recruitment Status: Recruiting
Phase: N/A
Date of Fir...